BTMD

#4218
Biote Corp. - Class A common stock
1.5 7 USD
-0.04%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.57
1.57
Intervallo Annuale
1.27
3.61
Variazione giornaliera
-3.68%
Variazione Mensile
-29.60%
Variazione di 6 mesi
-24.88%
Variazione Annuale
-53.27%
Chiusura Precedente
1.6 3
Open
1.5 7
Minimo
1.5 7
Massimo
1.5 7
Volume
7
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Documents

2026

Current report, Q3 FY2026
Biote Corp. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Biote Corp. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Biote Corp. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Biote Corp. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Biote Corp. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Biote Corp. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Biote Corp. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Biote Corp. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Biote Corp. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
Biote Corp. annual report, FY2025
10-K

Biote Corp. current report, Q2 FY2024

Full document

Biote Corp. Form 8-K Summary

Business Context and Reporting Period

This Current Report on Form 8-K was filed by Biote Corp. (BTMD) on June 14, 2024, with the report date of June 20, 2024. The filing discloses the entry into a Material Definitive Agreement regarding the settlement of litigation with stockholder Marci M. Donovitz.

Key Financial Metrics and Transaction Details

The filing details a stock repurchase and settlement agreement rather than standard operating financial results. Key transaction metrics include:

  • Total Settlement Value: $60 million in aggregate cash consideration.
  • Repurchase Price: Average of $7.23 per share.
  • Shares Repurchased: Approximately 8.3 million shares (Class A common units, Class V common stock, and Class A common stock).
  • Additional Cancellation: Approximately 4.0 million Paired Interests subject to earnout provisions will be released and cancelled for no additional monetary consideration.

Material Changes and Payment Schedule

The settlement resolves the "Donovitz Litigation" and involves a multi-year payment schedule for the $60 million repurchase:

  1. Initial Payment: $30 million for approximately 4.1 million shares on or before June 28, 2024.
  2. Year 1 Anniversary: $10 million for approximately 1.4 million shares.
  3. Year 2 Anniversary: $10 million for approximately 1.4 million shares.
  4. Year 3 Anniversary: $10 million for approximately 1.4 million shares.

The agreement includes a mutual release of claims, a voting agreement, and an acceleration clause in the event of a change of control.

Guidance, Outlook, and Risks

The filing does not provide updated financial guidance, revenue outlook, or management commentary on future operations. The primary risk addressed is the resolution of the Donovitz Litigation. The definitive Settlement Agreement is expected to supersede the current term sheet and will be filed in the next Form 10-Q.

Investor Verification Checklist

  • Verify the company's current cash position to confirm ability to fund the $30 million initial payment due by June 28, 2024.
  • Review the upcoming Form 10-Q for the full text of the definitive Settlement Agreement and any additional covenants.
  • Assess the impact of the $60 million cash outflow on the company's liquidity and working capital over the next 36 months.
  • Confirm the exact number of shares being cancelled versus repurchased to understand the dilution or accretion impact on remaining shareholders.

Notizie